Pharmaceutical pricing and reimbursement information (PPRI)-new PPRI analysis including Spain

Pharmaceuticals Policy and Law

Volumn 11, Issue 3, 2009, Pages 213-234

  Vogler, Sabine ^a   Espin, Jaime ^b   Habl, Claudia ^a  

^a Austrian Health Institute   (Austria)

^b ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85013620286     PISSN: 13892827     EISSN: 2210495X     Source Type: Journal    
DOI: 10.3233/PPL-2009-0222     Document Type: Article

References (9)

1. High Level Pharmaceutical Forum, Final Report of the High Level Pharmaceutical Forum 2005 -2008. Final Conclusions and Recommendations of the Pharmaceutical Forum, Brussels, October 2008.
2. High Level Pharmaceutical Forum, Building a toolbox of good practices to control budget, ensure access and rewards innovation, in online: http://ec.europa.eu/pharmaforum/pricing en.htm.
3. High Level Pharmaceutical Forum, Guiding principles for good practices implementing a pricing and reimbursement policy, in online: http://ec.europa.eu/pharmaforum/pricing en.htm.
4. J. Espin and J. Rovira, Analysis of differences and commonalities in pricing and reimbursement systems in Europe. A study funded by DG Enterprise and Industry of the European Commission, June 2007.
5. PPRI participants, PPRI Pharma Profiles, in online: http://ppri.oebig.at→Publications.
6. C. Habl et al., PPRI Glossary, in online: http://ppri.oebig.at →Glossary.
7. S. Vogler and I. Rosian, Set of Core PPRI Indicators, in online: http://ppri.oebig.at →Publications.
8. S. Vogler et al., PPRI Report, in online: http://ppri.oebig.at →Publications.
9. S. Vogler et al., PPRI at a Glance, in online: http://ppri.oebig.at →Publications.